Compendium of Cancer Genome Aberrations

CNS5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
Editor updated for a page on volunteer assignments
 
(31 intermediate revisions by 3 users not shown)
Line 5: Line 5:
If empty (no name is present), please volunteer to create content for that disease!
If empty (no name is present), please volunteer to create content for that disease!


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
 
__TOC__
<br />
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
Line 19: Line 18:
!'''Notes'''
!'''Notes'''
|-
|-
|Astrocystoma, IDH-Mutant
|
====CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
|Disease
|Disease
|Meenakshi Mehrotra
|Meenakshi Mehrotra
|6/25/2023
|6/25/2023
|
|
|PENDING
|COMPLETE
|
|
|Laveniya Satgunaseelan (LS)
|Laveniya Satgunaseelan (LS)
Line 30: Line 50:
|2021 template added
|2021 template added
|-
|-
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
|Disease
|Riley Lochner (trainee);
Shashi Shetty (mentor)
|6/7/2022
|6/7/2022
|
|
Line 39: Line 62:
|2021 template added
|2021 template added
|-
|-
|Glioblastoma, IDH-Wildtype||Disease||Meenakshi Mehrotra
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
|
|Disease
|
|Jieying Wu
|11/18/2025
|01/15/2026
|PENDING
|PENDING
|
|
|LS
|LS
|
|
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
|Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
|-
|-
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||Scott Smith
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
|Disease
|Scott Smith
|6/27/2023
|6/27/2023
|
|
|PENDING
|COMPLETE
|
|
|LS
|LS
Line 57: Line 84:
|2021 template added (page created 6/27/23)
|2021 template added (page created 6/27/23)
|-
|-
|Angiocentric Glioma||Disease||
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
|Disease
|
|
|
|
|
Line 66: Line 95:
|
|
|-
|-
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
|
|Disease
|
|
|
|
Line 73: Line 102:
|
|
|
|
|
|-
|Diffuse Low-Grade Glioma,  MAPK Pathway-Altered||Disease||
|
|
|
|
|
|
|-
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
|Disease
|Scott Smith
|5/3/2024
|
|
|PENDING - email reminder 9/4/2025
|
|
|LS
|
|
|
|
|-
|-
|Diffuse Midline Glioma, H3 K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
|
|Disease
|Laveniya Satgunaseelan
|
|
|12/06/2025
|PENDING
|PENDING
|
|
Line 93: Line 128:
|2021 template added
|2021 template added
|-
|-
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
|Disease
|Xiaolin (Lynn) Hu
|2/21/2022
|2/21/2022
|
|
Line 102: Line 139:
|2021 template added
|2021 template added
|-
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
|Disease
|Madina Sukhanova
|10/28/2022
|10/28/2022
|
|
Line 111: Line 161:
|2021 template added
|2021 template added
|-
|-
|Infant-Type Hemispheric Glioma||Disease||
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
|Disease
|
|
|
|
Line 118: Line 169:
|
|
|
|
|2021 template added
|-
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
|9/13/2022<br />
|
|
|PENDING
|
|-
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
|Disease
|
|<br />
|
|
|
|
|LS
|LS
Line 129: Line 183:
|2021 template added
|2021 template added
|-
|-
|High-Grade Astrocytoma with Piloid Features||Disease||
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
|Disease
|
|
|
|
|
Line 138: Line 194:
|
|
|-
|-
|Pleomorphic Xanthoastrocytoma||Disease||
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
|
|Disease
|
|Wahab Khan
|15/04/2025
|
|
|PENDING - email reminder 9/4/2025
|
|
|LS
|LS
Line 147: Line 205:
|2021 template added
|2021 template added
|-
|-
|Subependymal Giant Cell Astrocytoma||Disease||
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
|Disease
|
|
|
|
|
Line 156: Line 216:
|
|
|-
|-
|Chordoid Glioma||Disease||
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
|Disease
|
|
|
|
|
Line 165: Line 227:
|
|
|-
|-
|Astroblastoma, MN1-Altered||Disease||
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
|Disease
|
|
|
|
|
Line 174: Line 238:
|
|
|-
|-
|Ganglioglioma||Disease||Leila Moayed-Aloei
|[[CNS5:Ganglioglioma|Ganglioglioma]]
|Disease
|Leila Moayed-Aloei
|6/30/2022
|6/30/2022
|
|
Line 183: Line 249:
|2021 template added
|2021 template added
|-
|-
|Gangliocytoma||Disease||
|[[CNS5:Gangliocytoma|Gangliocytoma]]
|Disease
|
|
|
|
|
Line 192: Line 260:
|
|
|-
|-
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
|Disease
|
|
|
|
|
Line 201: Line 282:
|
|
|-
|-
|Dysembryoplastic Neuroepithelial Tumour||Disease||
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
|Disease
|
|
|
|
|
Line 210: Line 293:
|
|
|-
|-
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
|Disease
|
|
|
|
|
Line 219: Line 304:
|
|
|-
|-
|Papillary Glioneuronal Tumour||Disease||
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
|Disease
|
|
|
|
|
Line 228: Line 315:
|
|
|-
|-
|Rosette-Forming Glioneuronal Tumour||Disease||
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
|Disease
|
|
|
|
|
Line 237: Line 326:
|
|
|-
|-
|Myxoid Glioneuronal Tumour||Disease||
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
|Disease
|
|
|
|
|
Line 246: Line 337:
|
|
|-
|-
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
|
|Disease
|Laveniya Satgunaseelan
|9/11/2024
|
|
|COMPLETE
|8/7/2025
|LS
|LS
|Used for testing 9/2024 somatic template
|-
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
|Disease
|
|
|
|
Line 254: Line 355:
|
|
|
|
|-
|Multinodular and Vacuolating Neuronal Tumour||Disease||
|
|
|
|
|
|
|-
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
|Disease
|
|
|
|
|
|
|
|
|-
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
|
|
|
|
|
|
|
|
|-
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
|Disease
|
|
|
|
|
|
|-
|Central Neurocytoma||Disease||
|
|
|
|
Line 279: Line 380:
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
|Disease
|
|
|
|
|-
|Extraventricular Neurocytoma||Disease||
|
|
|
|
Line 289: Line 402:
|
|
|
|
|-
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
|Disease
|
|
|-
|Cerebellar Liponeurocytoma||Disease||
|
|
|
|
Line 300: Line 414:
|
|
|-
|-
|Supratentorial Ependymoma||Disease||
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
|Disease
|
|
|
|
|
Line 309: Line 425:
|
|
|-
|-
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
|Disease
|
|
|
|
|
Line 318: Line 436:
|
|
|-
|-
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
|Disease
|
|
|
|
|
Line 327: Line 447:
|
|
|-
|-
|Posterior Fossa Ependymoma||Disease||
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
|Disease
|
|
|
|
|
Line 336: Line 458:
|
|
|-
|-
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
|Disease
|
|
|
|
|
Line 345: Line 469:
|
|
|-
|-
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
|Disease
|
|
|
|
|
Line 354: Line 480:
|
|
|-
|-
|Spinal Ependymoma||Disease||
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
|Disease
|
|
|
|
|
Line 363: Line 491:
|
|
|-
|-
|Spinal Ependymoma, MYCN-Amplified||Disease||
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
|
|Disease
|
|
|
|
|
|
|
|-
|Myxopapillary Ependymoma||Disease||
|
|
|
|
Line 381: Line 502:
|
|
|-
|-
|Subependymoma||Disease||
!'''Disease'''
|
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
|Disease
|
|
|
|
Line 389: Line 521:
|
|
|
|
|-
|Choroid Plexus Papilloma||Disease||
|
|
|
|
|-
|[[CNS5:Subependymoma|Subependymoma]]
|Disease
|
|
|
|
Line 398: Line 531:
|
|
|
|
|-
|Atypical Choroid Plexus Papilloma||Disease||
|
|
|
|
|
|
|-
|
|
====CHAPTER 3 (CHOROID PLEXUS TUMOURS)====
|
|
----
|
|
----
|
|
|-
----
|Choroid Plexus Carcinoma||Disease||
|
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
|9/20/21
|Disease
|
|
|COMPLETE
|
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
|9/22/2022
|2021 template added
|-
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
|
|
|
|
Line 435: Line 567:
|
|
|-
|-
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
|Disease
|
|
|
|
|
Line 444: Line 578:
|
|
|-
|-
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
|
|Disease
|
|
|
|
Line 452: Line 586:
|
|
|
|
|-
|Medulloblastoma, Histologically Defined||Disease||
|
|
|
|
|-
|
|
====CHAPTER 4 (EMBRYONAL TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Atypical Teratoid/Rhabdoid Tumour||Disease||
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
|Disease
|Lisa Lansdon, PhD (LGG trainee just finished);
Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|
|
|COMPLETE
|
|
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
|9/22/2022
|2021 template added
|-
|-
|Cribriform Neuroepithelial Tumour||Disease||
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
|Disease
|
|
|
|
|
Line 480: Line 633:
|
|
|-
|-
|Embryonal Tumour with Multilayered Rosettes||Disease||
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
|Disease
|Hannah Wollenzien
|1/11/2026
|
|
|Pending
|
|
|MS
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
|Disease
|
|
|
|
|
|-
|CNS Neuroblastoma, FOXR2-Activated||Disease||
|
|
|
|
Line 496: Line 665:
|
|
|
|
|-
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
|Disease
|
|
|-
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
|
|
|
|
Line 507: Line 677:
|
|
|-
|-
|CNS Embryonal Tumour NEC/NOS||Disease||
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
|Disease
|
|
|
|
|
Line 516: Line 688:
|
|
|-
|-
|Pineocytoma||Disease||
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
|Disease
|
|
|
|
|
Line 525: Line 699:
|
|
|-
|-
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
|Disease
|
|
|
|
|
Line 534: Line 710:
|
|
|-
|-
|Pineoblastoma||Disease||
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
|Disease
|
|
|
|
|
Line 543: Line 721:
|
|
|-
|-
|Papillary Tumour of the Pineal Region||Disease||
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
|Disease
|
|
|
|
|
Line 552: Line 732:
|
|
|-
|-
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
|Disease
|
|
|
|
|
Line 561: Line 743:
|
|
|-
|-
|Schwannoma||Disease||
|
|
====CHAPTER 5 (PINEAL TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Neurofibroma||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Pineocytoma|Pineocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|Perineurioma||Disease||
|
|
|
|
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
|Disease
|
|
|
|
|
|
|-
|Hybrid Nerve Sheath Tumours||Disease||
|
|
|
|
Line 594: Line 796:
|
|
|
|
|-
|[[CNS5:Pineoblastoma|Pineoblastoma]]
|Disease
|Fang Fang (trainee)+Katie Schieffer (mentor)
|11/19/2025
|5/15/2026
|Pending
|
|LS
|
|
|
|
|-
|-
|Malignant Melanotic Nerve Sheath Tumour||Disease||
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
|Disease
|
|
|
|
|
Line 606: Line 819:
|
|
|-
|-
|Malignant Peripheral Nerve Sheath Tumour||Disease||
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
|Disease
|
|
|
|
|
Line 615: Line 830:
|
|
|-
|-
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
|
|
====CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Meningioma||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Schwannoma|Schwannoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|Solitary Fibrous Tumour||Disease||
|
|
|
|
|
|
|
|
|-
|[[CNS5:Neurofibroma|Neurofibroma]]
|Disease
|
|
|
|
|
|-
|Haemangiomas and Vascular Malformations||Disease||
|
|
|
|
Line 649: Line 872:
|
|
|
|
|-
|[[CNS5:Perineurioma|Perineurioma]]
|Disease
|
|
|-
|Haemangioblastoma||Disease||
|
|
|
|
Line 660: Line 884:
|
|
|-
|-
|Rhabdomyosarcoma||Disease||
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
|Disease
|
|
|
|
|
Line 669: Line 895:
|
|
|-
|-
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|
|
|
|
|
Line 678: Line 906:
|
|
|-
|-
|CIC-Rearranged Sarcoma||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|
|
|
|
|
Line 687: Line 928:
|
|
|-
|-
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
|Disease
|
|
|
|
|
Line 696: Line 939:
|
|
|-
|-
|Ewing Sarcoma||Disease||
|
|
====CHAPTER 7 (MENINGIOMA)====
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|-
|-
|Mesenchymal Chondrosarcoma||Disease||
|[[CNS5:Meningioma|Meningioma]]
|Disease
|
|
|
|
|
Line 714: Line 971:
|
|
|-
|-
|Chondrosarcoma||Disease||
|
|
====CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|
----
|-
|-
|Chordoma||Disease||
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|
|
|
|
|
Line 732: Line 1,003:
|
|
|-
|-
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
|Disease
|
|
|
|
|
Line 741: Line 1,014:
|
|
|-
|-
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
|Disease
|
|
|
|
|
Line 750: Line 1,025:
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
|Disease
|
|
|
|
|
Line 759: Line 1,036:
|
|
|-
|-
|Immunodeficiency-Associated CNS Lymphomas||Disease||
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
|Disease
|
|
|
|
|
Line 768: Line 1,047:
|
|
|-
|-
|Lymphomatoid Granulomatosis||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|
|
|
|
|
Line 777: Line 1,069:
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease||
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
|Disease
|
|
|
|
|
Line 786: Line 1,080:
|
|
|-
|-
|MALT Lymphoma of the Dura||Disease||
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|
|
|
|
|
Line 795: Line 1,091:
|
|
|-
|-
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|
|
|
|
|
Line 804: Line 1,102:
|
|
|-
|-
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||Jennie Thurston
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
|7/2/2023
|Disease
|
|
|
|
|PENDING
|
|
|MS
|
|
|2021 template added
|-
|T-cell and NK/T-cell Lymphomas||Disease||
|
|
|
|
|
|
|-
|[[CNS5:Chordoma|Chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
|
|
|
|
|
|-
|
|
====CHAPTER 9 (MELANOCYTIC TUMOURS)====
|
|
----
|
|
|-
----
|Rosai-Dorfman Disease||Disease||
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|Juvenile Xanthogranuloma||Disease||
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
|Disease
|
|
|
|
|
Line 849: Line 1,156:
|
|
|-
|-
|Langerhans Cell Histiocytosis||Disease||
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
|Disease
|
|
|
|
|
Line 858: Line 1,167:
|
|
|-
|-
|Histiocytic Sarcoma||Disease||
|
|
====CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Germ Cell Tumours of the CNS||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
|Disease
|
|
|
|
|
|
|
|
|-
|Adamantinomatous Craniopharyngioma||Disease||
|
|
|
|
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
|Disease
|
|
|
|
|
|
|-
|Papillary Craniopharyngioma||Disease||
|
|
|
|
Line 891: Line 1,220:
|
|
|
|
|-
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
|Disease
|
|
|
|
|-
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
|
|
|
|
Line 901: Line 1,231:
|
|
|
|
|-
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
|Disease
|
|
|-
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
|
|
|
|
Line 912: Line 1,243:
|
|
|-
|-
|Pituitary Blastoma||Disease||
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
|Disease
|
|
|
|
|
Line 921: Line 1,254:
|
|
|-
|-
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
|Disease
|
|
|
|
|
Line 930: Line 1,265:
|
|
|-
|-
|Metastases to the Meninges||Disease||
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
|
|Disease
|Jennie Thurston
|7/2/2023
|
|
|PENDING
|
|
|MS
|
|
|2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "[[HAEM5:ALK-positive anaplastic large cell lymphoma|ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]" and "[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]"?
|-
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
|Disease
|
|
|
|
|
|
|-
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
|
|
|
|
Line 945: Line 1,286:
|
|
|
|
|-
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
|Disease
|
|
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Neurofibromatosis Type 2||Disease||
|
|
|
|
Line 957: Line 1,298:
|
|
|-
|-
|Schwannomatosis||Disease||
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|
|
|
|
|
Line 966: Line 1,309:
|
|
|-
|-
|Von Hippel-Lindau Syndrome||Disease||
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
|Disease
|
|
|
|
Line 974: Line 1,318:
|
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|Tuberous Sclerosis||Disease||
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|Disease
|
|
|
|
|
Line 984: Line 1,342:
|
|
|-
|-
|Li-Fraumeni Syndrome||Disease||
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
|Disease
|
|
|
|
|
Line 993: Line 1,353:
|
|
|-
|-
|Cowden Syndrome||Disease||
|
|
====CHAPTER 11 (GERM CELL TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||Jennie Thurston
|7/2/2023
|
|
|PENDING
----
|
|
|LS
----
|
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
----
|-
|-
|Familial Adenomatous Polyposis 1||Disease||Jennifer Laffin
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
|8/22/2023
|Disease
|
|
|PENDING
|
|
|LS/MS
|
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
|
|
|
|
Line 1,026: Line 1,384:
|
|
|
|
|-
|
|
====CHAPTER 12 (TUMOURS OF THE SELLAR REGION====
|
|
|-
----
|Rhabdoid Tumour Predisposition Syndrome||Disease||
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|Carney Complex||Disease||
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
|Disease
|
|
|
|
|
Line 1,047: Line 1,417:
|
|
|-
|-
|DICER1 Syndrome||Disease||Jennie Thurston
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
|7/2/2023
|Disease
|
|PENDING
|
|
|LS
|
|
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|Familial Paraganglioma Syndromes||Disease||
|
|
|
|
Line 1,063: Line 1,427:
|
|
|
|
|-
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
|Disease
|
|
|-
|Melanoma-Astrocytoma Syndrome||Disease||
|
|
|
|
Line 1,074: Line 1,439:
|
|
|-
|-
|Familial Retinoblastoma||Disease||
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
|
|Disease
|
|
|
|
|
|
Line 1,083: Line 1,450:
|
|
|-
|-
|BAP1 Tumour Predisposition Syndrome||Disease||
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
|Disease
|
|
|
|
|
Line 1,092: Line 1,461:
|
|
|-
|-
|Fanconi Anaemia||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|
|
====CHAPTER 13 (METASTASES TO THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|
----
|-
|-
|ELP1-Medulloblastoma Syndrome||Disease||
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
|Disease
|
|
|
|
|
Line 1,110: Line 1,504:
|
|
|-
|-
|}<br />
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
{| class="wikitable" style="margin:auto"
|Disease
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
|
|-
|
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
|Disease
|Meenakshi Mehrotra
|6/25/2023
|
|
|PENDING
|
|
|Laveniya Satgunaseelan (LS)
|
|
|2021 template added
|-
|-
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
|Disease
|Riley Lochner (trainee), Shashi Shetty (mentor)
|6/7/2022
|
|
|COMPLETE
====CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)====
|
----
|
|
|LS
----
|
|
|2021 template added
----
|-
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
|Disease
|Meenakshi Mehrotra
|
|
----
|
|
|PENDING
----
|
|
|LS
----
|
|
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
----
|-
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
|Disease
|Scott Smith
|6/27/2023
|
|
|PENDING
----
|
|
|LS
----
|
|-
|2021 template added (page created 6/27/23)
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|-
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
|[[CNS5:Schwannomatosis|Schwannomatosis]]
|Disease
|Disease
|
|
Line 1,177: Line 1,569:
|
|
|-
|-
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
|Disease
|Disease
|
|
Line 1,199: Line 1,591:
|
|
|-
|-
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
|Disease
|[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
|Disease
|Disease
|Laveniya Satgunaseelan (Linda Cooley - previous version)
|
|
|
|
|PENDING
|
|
|LS
|
|
|2021 template added
|-
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
|Disease
|Xiaolin (Lynn) Hu
|2/21/2022
|
|
|COMPLETE
|
|
|LS
|
|
|2021 template added
|-
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
|Disease
|Madina Sukhanova
|10/28/2022
|
|COMPLETE
|
|
|LS
|
|2021 template added
|-
|-
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
|Disease
|Disease
|
|
Line 1,241: Line 1,666:
|
|
|
|
|2021 template added
|-
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
|Disease
|Jeremy Pulvers
|9/13/2022<br />
|
|PENDING
|
|
|LS
|
|2021 template added
|-
|-
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
|[[CNS5:Carney_complex|Carney complex]]
|Disease
|Disease
|
|
Line 1,265: Line 1,679:
|
|
|-
|-
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|LS
|N/A
|
|N/A
|2021 template added
|N/A
|-
|-
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
|Disease
|Disease
|
|
Line 1,287: Line 1,701:
|
|
|-
|-
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
|Disease
|Disease
|
|
Line 1,298: Line 1,712:
|
|
|-
|-
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
|Disease
|Disease
|
|
Line 1,309: Line 1,723:
|
|
|-
|-
|[[CNS5:Ganglioglioma|Ganglioglioma]]
!'''Disease'''
|Disease
!'''Page Type'''
|Leila Moayed-Aloei
!'''<span style="color:#0070C0">Author'''
|6/30/2022
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|COMPLETE
!'''Author Content (Pending or Complete)'''
|
!'''Date Completed by Author'''
|LS
!'''Associate Editor'''
|
!'''Date of Last Editor Review'''
|2021 template added
!'''Notes'''
|-
|[[CNS5:Gangliocytoma|Gangliocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Subependymoma|Subependymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
|Disease
|Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|
|COMPLETE
|
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
|9/22/2022
|2021 template added
|-
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pineocytoma|Pineocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pineoblastoma|Pineoblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Schwannoma|Schwannoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Neurofibroma|Neurofibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Perineurioma|Perineurioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Meningioma|Meningioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Chordoma|Chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
|Disease
|Jennie Thurston
|7/2/2023
|
|PENDING
|
|MS
|
|2021 template added
|-
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|Ngoni Faya (trainee) + Madina Sukhanova
|
|
|
|
|
|
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Schwannomatosis|Schwannomatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
|Disease
|Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
|Disease
|Jennifer Laffin
|8/22/2023
|
|PENDING
|
|LS/MS
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Carney_complex|Carney complex]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
|Disease
|Jennie Thurston
|7/2/2023
|
|PENDING
|
|LS
|
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|-
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
Line 2,433: Line 1,747:
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|-
|-
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
Retrieved from "https://test.ccga.io/index.php/CNS5:Volunteer_Assignments_and_Opportunities"